Literature DB >> 25894401

Surgical Management of Familial Papillary Thyroid Microcarcinoma: A Single Institution Study of 94 Cases.

Tae-Yon Sung1, Yu-mi Lee, Jong Ho Yoon, Ki-Wook Chung, Suck Joon Hong.   

Abstract

BACKGROUND: Familial papillary thyroid carcinoma (familial PTC) is well known to present with aggressiveness; however, the characteristics and the prognostic outcomes of familial papillary thyroid microcarcinoma (familial micro-PTC) are not well established. The overall aim of this study was to analyze the clinicopathological outcomes of familial micro-PTC.
METHODS: Between 1996 and 2006, 2071 patients underwent thyroid surgery for papillary thyroid carcinoma. The clinicopathological outcomes for familial PTC and sporadic PTC were compared, and familial micro-PTC data were sub-analyzed.
RESULTS: There were significant differences in multifocality, bilaterality, extent of surgery, and recurrence between familial PTC and sporadic PTC (p<0.05). There was no significant difference in the number of affected family members in the familial PTC group. In patients with familial micro-PTC, less aggressiveness was noted in multifocality, extrathyroidal invasion, tumor stage at time of initial surgery, central lymph node metastasis, and recurrence than in those with familial PTC tumors>1 cm in diameter (p<0.05). The multivariate analysis including recurrence showed no significant difference between familial micro-PTC patients and sporadic micro-PTC patients.
CONCLUSION: When familial PTC was compared with sporadic PTC, our results support the recommendation for more invasive familial PTC surgery. However, familial micro-PTC outcomes differed from familial PTC tumors>1.0 cm in diameter. It was similar to sporadic micro-PTC, illustrating that familial micro-PTC is less aggressive and that a less invasive surgical treatment could be considered.

Entities:  

Mesh:

Year:  2015        PMID: 25894401     DOI: 10.1007/s00268-015-3064-y

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  22 in total

1.  Does familial non-medullary thyroid cancer adversely affect survival?

Authors:  Frederic Triponez; Mariwil Wong; Cord Sturgeon; Nadine Caron; David G Ginzinger; Mark R Segal; Electron Kebebew; Quan-Yang Duh; Orlo H Clark
Journal:  World J Surg       Date:  2006-05       Impact factor: 3.352

Review 2.  Papillary and follicular thyroid carcinoma.

Authors:  M J Schlumberger
Journal:  N Engl J Med       Date:  1998-01-29       Impact factor: 91.245

Review 3.  Familial thyroid cancer.

Authors:  O Alsanea; O H Clark
Journal:  Curr Opin Oncol       Date:  2001-01       Impact factor: 3.645

Review 4.  Thyroid carcinoma.

Authors:  Steven I Sherman
Journal:  Lancet       Date:  2003-02-08       Impact factor: 79.321

Review 5.  Familial nonmedullary thyroid cancer.

Authors:  Cord Sturgeon; Orlo H Clark
Journal:  Thyroid       Date:  2005-06       Impact factor: 6.568

6.  Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population.

Authors:  Shinya Uchino; Shiro Noguchi; Hitoshi Kawamoto; Hiroyuki Yamashita; Shin Watanabe; Hiroto Yamashita; Shigeru Shuto
Journal:  World J Surg       Date:  2002-04-30       Impact factor: 3.352

7.  Increasing incidence of thyroid cancer is due to increased pathologic detection.

Authors:  Simon Grodski; Tani Brown; Stan Sidhu; Anthony Gill; Bruce Robinson; Diana Learoyd; Mark Sywak; Tom Reeve; Leigh Delbridge
Journal:  Surgery       Date:  2008-12       Impact factor: 3.982

Review 8.  Familial thyroid carcinoma: a diagnostic algorithm.

Authors:  Jorge Dotto; Vânia Nosé
Journal:  Adv Anat Pathol       Date:  2008-11       Impact factor: 3.875

9.  Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity.

Authors:  M Capezzone; S Marchisotta; S Cantara; G Busonero; L Brilli; K Pazaitou-Panayiotou; A F Carli; G Caruso; P Toti; S Capitani; A Pammolli; F Pacini
Journal:  Endocr Relat Cancer       Date:  2008-10-02       Impact factor: 5.678

Review 10.  An evidence-based approach to familial nonmedullary thyroid cancer: screening, clinical management, and follow-up.

Authors:  Rebecca S Sippel; Nadine R Caron; Orlo H Clark
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

View more
  6 in total

1.  Familial Papillary Thyroid Carcinoma (FPTC): a Retrospective Analysis in a Sample of the Bulgarian Population for a 10-Year Period.

Authors:  Kalin Vidinov; Dragomira Nikolova
Journal:  Endocr Pathol       Date:  2017-03       Impact factor: 3.943

2.  Biological behavior of familial papillary thyroid microcarcinoma: Spanish multicenter study.

Authors:  A Ríos; M A Rodríguez; J A Puñal; P Moreno; E Mercader; E Ferrero; J Ruiz-Pardo; M A Morlán; J Martín; M Durán-Poveda; J M Bravo; D Casanova; M P Salvador Egea; N M Torregrosa; A Exposito-Rodríguez; G Martínez-Fernández; A M Carrión; O Vidal; F Herrera; G Ruiz-Merino; J M Rodríguez
Journal:  Langenbecks Arch Surg       Date:  2022-10-17       Impact factor: 2.895

3.  Incidental and non-incidental thyroid microcarcinoma.

Authors:  Krzysztof Kaliszewski; Beata Wojtczak; Marta Strutyńska-Karpińska; Tadeusz Łukieńczuk; Zdzisław Forkasiewicz; Paweł Domosławski
Journal:  Oncol Lett       Date:  2016-05-30       Impact factor: 2.967

4.  Should Total Thyroidectomy Be Recommended for Patients with Familial Non-medullary Thyroid Cancer?

Authors:  Yon Seon Kim; Minjung Seo; Seol Hoon Park; So Yeon Ju; Eun Sook Kim
Journal:  World J Surg       Date:  2020-09       Impact factor: 3.352

5.  The clinicopathologic characteristics of familial and sporadic papillary thyroid carcinoma in Turkish patients

Authors:  Havva Sezer; Mehmet Onur Demirkol; Dilek Yazici; Yersu Kapran; Mahmut Faruk Alagöl
Journal:  Turk J Med Sci       Date:  2020-04-09       Impact factor: 0.973

Review 6.  Inherited Follicular Epithelial-Derived Thyroid Carcinomas: From Molecular Biology to Histological Correlates.

Authors:  José Manuel Cameselle-Teijeiro; Ozgur Mete; Sylvia L Asa; Virginia LiVolsi
Journal:  Endocr Pathol       Date:  2021-01-25       Impact factor: 3.943

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.